The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALIBABA GROUP HLDG LTD | SPONSORED ADS | 01609W102 | BBG012GS21K8 | 16,632,000 | 220,000 | SH | Call | SOLE | N/A | 220,000 | 0 | 0 |
| ATOUR LIFESTYLE HLDGS LTD | SPONSORED ADS | 04965M106 | BBG011C6KK02 | 1,128,400 | 65,000 | SH | SOLE | N/A | 65,000 | 0 | 0 | |
| PDD HOLDINGS INC | NOTE 12/0 | 722304AC6 | BBG00Y78WSB1 | 4,139,262 | 4,000,000 | PRN | SOLE | N/A | 4,000,000 | 0 | 0 | |
| YS BIOPHARMA CO LTD | *W EXP 03/15/202 | G9845F117 | BBG01FY54DL0 | 14,905 | 550,000 | SH | SOLE | N/A | 550,000 | 0 | 0 | |